COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas (PDT-Vismo)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02639117
Recruitment Status : Completed
First Posted : December 24, 2015
Last Update Posted : July 18, 2018
Genentech, Inc.
Information provided by (Responsible Party):
University of Arizona

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 2, 2016
Actual Study Completion Date : November 18, 2017